bf/NASDAQ:VTGN_icon.png

COM:VISTAGEN

Vistagen Therapeutics, Inc

  • Stock

Last Close

2.53

22/11 21:00

Market Cap

94.05M

Beta: -

Volume Today

264.24K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
1.25M
-
1.09M
-
1.11M
1.78%
-227.30K
120.50%
1.06M
568.10%
cost of revenue
568K
-
gross profit
1.25M
-
1.09M
-
1.11M
1.78%
-227.30K
120.50%
496K
318.21%
selling and marketing expenses
2.80M
-
1.90M
31.90%
general and administrative expenses
2.55M
-
4.25M
66.62%
13.92M
227.80%
5.87M
57.84%
6.44M
9.70%
7.43M
15.46%
6.60M
11.19%
6.55M
0.80%
10.45M
59.65%
14.66M
40.29%
14.06M
4.10%
selling general and administrative expenses
2.55M
-
4.25M
66.62%
13.92M
227.80%
5.87M
57.84%
6.44M
9.70%
7.43M
15.46%
6.60M
11.19%
6.55M
0.80%
13.25M
102.35%
14.66M
10.69%
14.06M
4.10%
research and development expenses
2.48M
-
2.43M
1.93%
3.93M
61.61%
5.20M
32.36%
7.76M
49.17%
17.10M
120.27%
13.37M
21.78%
12.48M
6.71%
35.41M
183.80%
44.38M
25.33%
20.02M
54.88%
other expenses
-233K
-
-2.30K
99.01%
-427K
18,465.22%
-428K
0.23%
-48.70K
88.62%
-827K
1,598.15%
600
100.07%
312K
-
cost and expenses
5.03M
-
6.68M
32.81%
17.85M
167.27%
11.07M
37.97%
14.20M
28.25%
24.53M
72.75%
19.97M
18.57%
19.02M
4.76%
48.66M
155.77%
59.04M
21.34%
34.09M
42.27%
operating expenses
5.03M
-
6.68M
32.81%
17.85M
167.27%
11.07M
37.97%
14.20M
28.25%
24.53M
72.75%
19.97M
18.57%
19.02M
4.76%
48.66M
155.77%
59.04M
21.34%
34.09M
42.27%
interest expense
1.56M
-
4.62M
195.58%
777K
83.17%
5K
99.36%
8.90K
78%
-8M
89,987.64%
15K
100.19%
13K
13.33%
232K
1,684.62%
23K
90.09%
ebitda
-4.96M
-
-6.85M
37.94%
-17.80M
159.92%
-10.19M
42.73%
-14.20M
39.30%
-24.44M
72.11%
-20.65M
15.49%
-17.80M
13.81%
-46.82M
163.00%
-59.27M
26.60%
-33.02M
44.29%
operating income
-5.03M
-
-6.78M
34.76%
-17.85M
163.39%
-10.25M
42.59%
-14.20M
38.55%
-24.56M
72.94%
-20.80M
15.29%
-17.93M
13.79%
-47.78M
166.42%
-59.27M
24.05%
-33.02M
44.29%
depreciation and amortization
54.60K
-
59.10K
8.24%
53.50K
9.48%
54.90K
2.62%
80.70K
46.99%
91.20K
13.01%
148.20K
62.50%
132.80K
10.39%
963K
625.15%
531.20K
44.84%
568K
6.93%
total other income expenses net
3.62M
-
-2.59M
171.70%
-28.59M
1,002.80%
-427K
98.51%
-135K
68.38%
-48.70K
63.93%
30.10K
161.81%
2.20K
92.69%
19.90K
804.55%
26.20K
31.66%
3.66M
13,880.92%
income before tax
-2.96M
-
-13.88M
368.24%
-47.22M
240.11%
-10.25M
78.29%
-14.34M
39.89%
-24.59M
71.42%
-20.77M
15.52%
-17.93M
13.67%
-47.76M
166.34%
-59.24M
24.04%
-29.36M
50.44%
income tax expense
2.70K
-
2.40K
11.11%
2.30K
4.17%
2.40K
4.35%
2.40K
0%
2.60K
8.33%
2.60K
0%
2.60K
0%
3.40K
30.77%
5.90K
73.53%
4K
32.20%
net income
-2.97M
-
-13.89M
367.90%
-47.22M
240.06%
-10.26M
78.28%
-14.35M
39.88%
-24.59M
71.41%
-20.77M
15.52%
-17.93M
13.67%
-47.76M
166.32%
-59.25M
24.05%
-29.36M
50.45%
weighted average shs out
36.62K
-
43.96K
20.03%
58.93K
34.06%
251.05K
326.01%
463.00K
84.42%
952.08K
105.63%
1.46M
53.59%
2.87M
96.34%
197.98M
6,795.52%
6.96B
3,414.90%
19.35M
99.72%
weighted average shs out dil
36.64K
-
43.96K
19.98%
58.93K
34.06%
251.05K
326.01%
463.00K
84.42%
952.08K
105.63%
1.46M
53.59%
2.87M
96.34%
197.98M
6,795.52%
6.96B
3,414.90%
19.35M
99.72%
eps
-81.03
-
-315.87
289.82%
-801.28
153.67%
-40.85
94.90%
-30.98
24.16%
-25.83
16.62%
-14.21
44.99%
-6.25
56.02%
-0.24
96.16%
-0.01
96.46%
-1.52
17,782.35%
epsdiluted
-81
-
-315.87
289.96%
-801.28
153.67%
-40.85
94.90%
-30.98
24.16%
-25.83
16.62%
-14.21
44.99%
-6.25
56.02%
-0.24
96.16%
-0.01
96.46%
-1.52
17,782.35%

All numbers in (except ratios and percentages)